I

Imexpharm Corp
VN:IMP

Watchlist Manager
Imexpharm Corp
VN:IMP
Watchlist
Price: 53 800 VND 0.37% Market Closed
Market Cap: 8.3T VND

Net Margin

13%
Current
Improving
by 0.5%
vs 3-y average of 12.6%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
13%
=
Net Income
₫319.7B
/
Revenue
₫2.5T

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
13%
=
Net Income
₫319.7B
/
Revenue
₫2.5T

Peer Comparison

Country Company Market Cap Net
Margin
VN
Imexpharm Corp
VN:IMP
8.3T VND
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
521.4B USD
Loading...
CH
Roche Holding AG
SIX:ROG
274B CHF
Loading...
CH
Novartis AG
SIX:NOVN
219.7B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
206.4B GBP
Loading...
US
Merck & Co Inc
NYSE:MRK
276.8B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
146.4B USD
Loading...
No Stocks Found

Market Distribution

Higher than 76% of companies in Vietnam
Percentile
76th
Based on 660 companies
76th percentile
13%
Low
-67 046.2% — 1.4%
Typical Range
1.4% — 9.8%
High
9.8% — 1 155.9%
Distribution Statistics
Vietnam
Min -67 046.2%
30th Percentile 1.4%
Median 4%
70th Percentile 9.8%
Max 1 155.9%

Imexpharm Corp
Glance View

Market Cap
8.3T VND
Industry
Pharmaceuticals

Imexpharm Corp. engages in the manufacture, import, export and trade of pharmaceuticals, medicinal chemicals and botanical. The company is headquartered in Cao Lanh, Dong Thap and currently employs 1,356 full-time employees. The company went IPO on 2006-12-04. The firm manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. The company is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.

IMP Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
13%
=
Net Income
₫319.7B
/
Revenue
₫2.5T
What is Imexpharm Corp's current Net Margin?

The current Net Margin for Imexpharm Corp is 13%, which is above its 3-year median of 12.6%.

How has Net Margin changed over time?

Over the last 3 years, Imexpharm Corp’s Net Margin has decreased from 13.9% to 13%. During this period, it reached a low of 11.2% on Dec 31, 2022 and a high of 13.9% on Dec 31, 2023.

Back to Top